Remove healthcare-authority digital-health-technology
article thumbnail

Watchdog fears healthcare tech merger could push up NHS costs

The Guardian M&A

CMA gives UnitedHealth and EMIS five working days to tackle concerns over £1.2bn deal The competition watchdog has warned that a proposed merger between two healthcare technology specialists would lead to higher costs and “worse outcomes for the NHS and ultimately patients and UK taxpayers”. Continue reading.

article thumbnail

Cooley’s 2022 Tech M&A Year in Review

Cooley M&A

Similarly, we expect sponsors to actively pursue carve out opportunities – like Francisco Partners’ carve out acquisition of the data and analytics assets from IBM’s Watson Health business – in 2023 as tech giants streamline their portfolios to focus on their core businesses.

Equity 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Anticipating a Scandal: Is AI a Ticking Time Bomb for Companies?

Internal Audit 360

Artificial Intelligence technology as it evolves is certain to contribute to the creation, preservation, and destruction of stakeholder value in the coming weeks, months, and years. AI technologies can be vulnerable to cyberattacks which can compromise assets (including sensitive data), disrupt operations, or even cause physical harm.

article thumbnail

Appraiser Newsroom - Untitled Article

Appraiser Newsroom

Mr. Anastasiou specializes in digital assets and decentralized finance (“DeFi”). His experience in the field extends into various areas including, digital asset valuation, financial due diligence, investigations and securities litigation. Ronald Seigneur , MBA CPA/ABV ASA CVA, is Managing Partner of Seigneur Gustafson LLP.

article thumbnail

Cooley’s 2021 Life Sciences M&A Year in Review

Cooley M&A

Increased focus on digitization, with life sciences companies placing a premium on innovative and tech?driven In June, GlaxoSmithKline announced its plans to spin off its consumer healthcare business to focus on its pharmaceutical and vaccine businesses. Of the 20 largest public deals in the healthcare sector in 2021, 14 featured all?cash

article thumbnail

Davis Polk Discusses Biden’s Executive Order on Competition, One Year Later

Reynolds Holding

The Executive Order highlighted several particular sectors of concern (namely agriculture, information technology, healthcare and prescription drugs, telecommunications, and labor, including a focus on non-compete provisions that impact workers), but the call for stronger antitrust enforcement was economy-wide. are strongly enforced.

article thumbnail

Antitrust Trends to Look Out for in 2022

Cooley M&A

Legislators have introduced a variety of bills that could lead to restrictions on conduct in the technology and life science sectors. FTC unanimously ruled that the FTC does not have authority to seek monetary relief under Section 13(b). Substantively, merging companies are facing greater scrutiny and novel antitrust theories of harm.